J. Marolleau

发表

Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants.

S. Chevret, M. Carmagnat, H. Bittencourt, 2001, Experimental hematology.

Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favorable Hodgkin's disease.

C. Gisselbrecht, M. Boiron, J. Trédaniel, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Human cytomegalovirus infection of bone marrow myofibroblasts enhances myeloid progenitor adhesion and elicits viral transmission.

M. Prevost, P. Rohrlich, E. Perret, 2001, Microbes and infection.

High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma

C. Gisselbrecht, C. Lebbé, L. Dubertret, 2004, Bone Marrow Transplantation.

Secondary acute myeloid leukemia after autologous bone marrow transplantation for malignant lymphomas.

C. Gisselbrecht, P. Morel, P. Brice, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas.

H. Dombret, A. Baruchel, C. Gisselbrecht, 1992, Bone marrow transplantation.

Myelodysplasias and leukemias after autologous stem cell transplantation for lymphoid malignancies

C. Gisselbrecht, P. Morel, P. Rousselot, 2000, Bone Marrow Transplantation.

First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin’s lymphoma

O. Casasnovas, N. Mounier, M. Erlanson, 2017, Bone Marrow Transplantation.

Genomic organization of the mouse T cell receptor V alpha family.

B. Malissen, I. Hue, M. Malissen, 1990, The EMBO journal.

Influence of CD34+ marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia

S. Chevret, H. Bittencourt, H. Esperou, 2001, Bone Marrow Transplantation.

Molecular and clinical diversity in primary central nervous system lymphoma.

K. Hoang-Xuan, O. Chinot, K. Mokhtari, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.

C. Gisselbrecht, M. Rybojad, P. Morel, 1995, Archives of dermatology.

Successful interleukin‐2 therapy of advanced cutaneous T‐cell lymphoma

C. Gisselbrecht, M. Rybojad, P. Morel, 1992, The British journal of dermatology.

[Epidermotropic T-cell gamma/delta lymphoma].

C. Gisselbrecht, L. Dubertret, S. Aractingi, 1993, Annales de dermatologie et de venereologie.

The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomas.

C. Gisselbrecht, É. Lepage, J. Trédaniel, 1992, The European respiratory journal.

Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma

J. Fermand, J. Marolleau, M. Benbunan, 1999, Bone Marrow Transplantation.

Influence of CD34 cell selection on the incidence of mixed chimaerism and minimal residual disease after allogeneic unrelated donor transplantation

H. Esperou, G. Socié, E. Gluckman, 1998, Leukemia.

Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: a pilot study of 36 patients.

P. Gaulard, B. Quesnel, C. Gisselbrecht, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[Subcutaneous localizations of Burkitt's lymphoma at laparoscopic insertion sites].

L. Dubertret, S. Aractingi, M. Daniel, 1993, Annales de dermatologie et de venereologie.

STEM CELL COLLECTION AFTER FAILURE OF UPFRONT ABVD OR BEACOPP IN PATIENTS WITH HIGH RISK ADVANCED STAGE III-IV HODGKIN'S LYMPHOMA

O. Casasnovas, N. Mounier, M. Erlanson, 2016 .

R‐CHOP +/‐RADIOTHERAPY IN NON‐BULKY LIMITED‐STAGE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FINAL RESULTS OF THE PROSPECTIVE RANDOMIZED PHASE III 02‐03 TRIAL FROM THE LYSA/GOELAMS

T. Fest, M. Béné, V. Costes, 2017 .

Treatment of relapsed and refractory Hodgkin's disease with high dose chemotherapy and autologous bone marrow transplantation.

A. Baruchel, C. Gisselbrecht, M. Boiron, 1991, Nouvelle revue francaise d'hematologie.

[Methotrexate-induced skin detachment].

C. Gisselbrecht, L. Dubertret, P. Brice, 1992, Presse medicale.

Autoimmune hemolytic anemia disclosing Hodgkin's disease associated with Castleman's disease.

C. Gisselbrecht, P. Brice, B. Epardeau, 1991, Nouvelle revue francaise d'hematologie.

Disseminated toxoplasmosis following autologous bone marrow transplantation.

C. Gisselbrecht, F. Geissmann, F. Derouin, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Middle-term evolution of patients with advanced cutaneous T-cell lymphoma treated with high-dose recombinant interleukin-2.

M. Rybojad, J. Marolleau, M. Baccard, 1997, Archives of Dermatology.

Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study

R. Houot, K. Hoang-Xuan, O. Casasnovas, 2023, Annals of Hematology.

CD14+ CD16+ monocytes rather than CD14+ CD51/61+ monocytes are a potential cytological marker of circulating osteoclast precursors in multiple myeloma. A preliminary study

N. Guillaume, S. Kamel, J. Desoutter, 2015, International journal of laboratory hematology.

High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study

M. Espié, A. Roquancourt, A. de Roquancourt, 2001, British Journal of Cancer.

Comparison of autografting using mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas.

C. Haioun, F. Reyes, P. Brice, 1994, Bone marrow transplantation.